This Guideline supersedes Guideline UST-42 as of 31 October 2023.
The Guideline is based upon legislative conditions stipulated by:
- Act No 40/1995 Coll., on Advertising Regulation and on Amendments to Act No 468/1991 Coll., on the Operation of Radio and Television Broadcasting, as amended (hereinafter referred to as “Act No 40/1995 Coll., on Advertising Regulation”)
This Guideline applies only to advertising for medical devices (hereinafter referred to as “MD(s)”) and in vitro diagnostic medical devices (hereinafter referred to as “IVD(s)”) and provides greater detail to the information presented in Guideline UST-39 Regulation of Advertising for Medical Devices and in Vitro Diagnostic Medical Devices concerning the sponsoring and provision of gifts and other benefits to experts and employees of healthcare providers in advertising for MDs and IVDs referred to under Act No 40/1995 Coll., on Advertising Regulation, falling within the powers of the State Institute for Drug Control (hereinafter referred to as the “Institute”). The Guideline is of recommendatory nature.
This Guideline applies to the provision of gifts or other benefits and to sponsoring targeted at persons authorised to prescribe and dispense MDs and IVDs and at employees of healthcare providers. The purpose of the legislative conditions is, inter alia, that experts and employees of healthcare service providers perform their tasks objectively without being influenced by direct or indirect financial incentives in the prescribing, dispensing, use, and ordering of MDs and IVDs.
cz